Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.
00:00 – Introduction
03:30 – Understanding Hormonal Variability and Fertility Gaps
05:00 – Why Mira Launched in 2017: Timing and Market Needs
08:00 – Early Feedback from Consumers, Doctors, and Investors
11:32 – Challenges of Raising Funds in the Women’s Health Space
13:50 – Developing Mira’s Product with Limited Research
18:15 – The Impact of the Pandemic on Mira’s Growth
20:16 – Pricing Strategy and Making Mira Accessible
23:33 – Working with Insurance and Healthcare Providers
25:01 – Navigating the FDA Approval Process
28:01 – The Role of AI in Mira’s Hormonal Health Analysis
31:08 – From Corporate Leadership to Entrepreneurship
35:34 – Sylvia’s Leadership Style and Mira’s Company Culture
38:47 – The Future of Women’s Health and Mira’s Expansion Plans
Found posts every Tuesday. Subscribe on Apple (https://podcasts.apple.com/podcast/id1624500693) , Spotify (https://open.spotify.com/show/7gaqQOeUbC6hfMkVA5fih3?si=9aa4bf8b73bf4a8c) or wherever you listen to podcasts (https://pod.link/techcrunchpodcast) to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity (https://pod.link/equity) . Subscribe to Found (https://pod.link/found) to hear more stories from founders each
Connect with us:
• On Twitter (https://twitter.com/found)
• On Instagram (https://www.instagram.com/foundpod/)
• Via email: found@techcrunch.com
